Fangchinoline (Wuhan Institute of Virology)

N/A

Report date: 2025/01/26 18:04:54
NME

Base Information

Drug NameFangchinoline (Wuhan Institute of Virology)
Drug Alias Namefangchinoline
ClassificationNatural product/ExtractSmall molecules
Mechanisms of ActionEnvelope glycoprotein gp160 inhibitors
TargetsEnvelope glycoprotein gp160
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesWuhan Institute Of Virology, Chinese Academy Of Sciences
China Registration ClassN/A

Develop Information

Active CompaniesWuhan Institute Of Virology, Chinese Academy Of Sciences
Inactive CompaniesN/A
Active IndicationsHIV Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A